Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026)
Viemed Healthcare (VMD) posted Cash from Investing Activities of -$5.5 million for Q1 2026, up 27.94% on a QoQ basis from -$7.6 million in Q4 2025, and up 35.7% year-over-year from -$4.0 million in Q1 2025.
Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Viemed Healthcare's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$5.5 million for Q1 2026.
- Quarterly Cash from Investing Activities rose 35.7% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.1 million (down 39.15% YoY) and the FY2025 annual result came in at -$50.2 million, down 63.41% from the prior year.
- Cash from Investing Activities was -$5.5 million for Q1 2026 at Viemed Healthcare, up from -$7.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1.7 million in Q2 2025 and bottomed at -$32.3 million in Q3 2025.
- A 5-year average of -$9.6 million and a median of -$7.4 million in 2022 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 84.53% in 2025, while the deepest fall reached 549.97% in 2025.
- Viemed Healthcare's Cash from Investing Activities stood at -$7.4 million in 2022, then decreased by 1.56% to -$7.5 million in 2023, then dropped by 22.75% to -$9.2 million in 2024, then grew by 17.24% to -$7.6 million in 2025, then increased by 27.94% to -$5.5 million in 2026.
- Business Quant data shows VMD's Cash from Investing Activities at -$5.5 million in Q1 2026, -$7.6 million in Q4 2025, and -$32.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Viemed Healthcare | 464.60 Mn | 454.84 Mn | 42.83 Mn | -5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.49 Mn |
| Mar 31, 2026 | -5.49 Mn |
| Dec 31, 2025 | -7.61 Mn |
| Dec 31, 2025 | -7.61 Mn |
| Sep 30, 2025 | -32.30 Mn |
| Sep 30, 2025 | -32.30 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -8.53 Mn |
| Mar 31, 2025 | -8.53 Mn |
| Dec 31, 2024 | -9.20 Mn |
| Dec 31, 2024 | -9.20 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -11.17 Mn |
| Jun 30, 2024 | -11.17 Mn |
| Mar 31, 2024 | -5.37 Mn |
| Mar 31, 2024 | -5.37 Mn |
| Dec 31, 2023 | -7.49 Mn |
| Dec 31, 2023 | -7.49 Mn |